US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist

9.760
-0.010-0.10%

Trading Nov 27 12:50 ET

1.58BMarket Cap8.79P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.91%-33.48M

-81.03%-56.16M

-30.01%-42.96M

-42.11%-163.28M

-69.41%-51.44M

-85.43%-47.77M

-16.71%-31.02M

-2.66%-33.04M

-52.34%-114.9M

-3.45%-30.37M

Net income from continuing operations

-36.81%-72.55M

-52.30%-58.7M

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

Operating gains losses

----

-988.68%-577K

---316K

Depreciation and amortization

-9.83%156K

-6.43%160K

0.00%158K

12.46%668K

12.93%166K

18.49%173K

11.04%171K

7.48%158K

10.41%594K

12.21%147K

Other non cash items

-0.58%854K

-4.47%812K

-2.83%791K

338.98%67.38M

8,017.15%64.86M

-16.44%859K

181.46%850K

-93.84%814K

-90.29%15.35M

-0.50%799K

Change In working capital

2,567.23%29.43M

-277.22%-9.03M

1,062.14%3.59M

-28.08%-8.9M

-153.27%-13.11M

-314.95%-1.19M

194.62%5.1M

107.62%309K

-623.00%-6.95M

-15.56%-5.18M

-Change in prepaid assets

356.79%17.69M

-129.56%-9.74M

-6.45%7.35M

-214.25%-11.4M

-293.18%-8.13M

-642.46%-6.89M

-3,219.12%-4.24M

1,121.85%7.86M

-60.53%-3.63M

8.98%-2.07M

-Change in payables and accrued expense

91.93%12.6M

-84.97%1.53M

56.16%-2.96M

305.96%5.91M

-203.85%-4.07M

207.69%6.57M

466.28%10.16M

37.03%-6.75M

-149.41%-2.87M

133.39%3.92M

-Change in other current assets

----

--0

----

137.48%1.37M

-72.46%-6.25M

-Change in other current liabilities

0.92%-861K

-0.24%-822K

-0.12%-802K

-86.36%-3.4M

-16.90%-913K

-44.35%-869K

-310.00%-820K

-229.63%-801K

-117.12%-1.83M

-194.72%-781K

Cash from discontinued investing activities

Operating cash flow

29.91%-33.48M

-81.03%-56.16M

-30.01%-42.96M

-42.11%-163.28M

-69.41%-51.44M

-85.43%-47.77M

-16.71%-31.02M

-2.66%-33.04M

-52.34%-114.9M

-3.45%-30.37M

Investing cash flow

Cash flow from continuing investing activities

559.20%156.99M

-11.72%21.26M

-5,424.85%-150M

138.32%64.39M

270.32%13.68M

42.66%23.82M

126.44%24.08M

103.29%2.82M

-20,464.63%-168.01M

-4,171.28%-8.03M

Net PPE purchase and sale

--0

77.10%-117K

-91.30%-44K

71.54%-37K

--0

79.55%-36K

37.45%-511K

87.77%-23K

Net investment purchase and sale

558.18%156.99M

-11.72%21.26M

-5,330.49%-149.23M

144.72%69.09M

328.69%18.31M

41.78%23.85M

126.49%24.08M

103.94%2.85M

---154.5M

---8.01M

Net other investing changes

--0

---775K

64.69%-4.59M

----

---13M

--0

Cash from discontinued investing activities

Investing cash flow

559.20%156.99M

-11.72%21.26M

-5,424.85%-150M

138.32%64.39M

270.32%13.68M

42.66%23.82M

126.44%24.08M

103.29%2.82M

-20,464.63%-168.01M

-4,171.28%-8.03M

Financing cash flow

Cash flow from continuing financing activities

-99.34%1.53M

808.90%2.65M

1,726.73%1.85M

100.39%231.94M

-101.79%-481K

166.15%232.02M

-85.98%292K

128.77%101K

-60.57%115.74M

7,595.25%26.83M

Net common stock issuance

----

--232.88M

---491K

----

--0

Net preferred stock issuance

----

--0

----

-61.46%112.22M

39,738.10%24.97M

Proceeds from stock option exercised by employees

16.21%1.76M

556.93%2.65M

1,562.16%1.85M

-33.13%2.86M

-49.85%830K

949.31%1.51M

-82.50%404K

-32.32%111K

70.23%4.27M

95.63%1.66M

Net other financing activities

----

-411.29%-3.8M

-498.06%-820K

-1,262.86%-2.86M

50.22%-112K

98.06%-10K

34.79%-744K

--206K

Cash from discontinued financing activities

Financing cash flow

-99.34%1.53M

808.90%2.65M

1,726.73%1.85M

100.39%231.94M

-101.79%-481K

166.15%232.02M

-85.98%292K

128.77%101K

-60.57%115.74M

7,595.25%26.83M

Net cash flow

Beginning cash position

-26.06%151.89M

-13.18%184.14M

54.93%375.25M

-40.83%242.21M

62.94%413.5M

16.95%205.43M

-27.18%212.08M

-40.83%242.21M

113.10%409.37M

-42.23%253.77M

Current changes in cash

-39.91%125.04M

-384.80%-32.25M

-534.44%-191.11M

179.59%133.05M

-230.76%-38.25M

166.39%208.07M

94.24%-6.65M

74.50%-30.12M

-176.94%-167.17M

61.33%-11.56M

End cash Position

-33.03%276.93M

-26.06%151.89M

-13.18%184.14M

54.93%375.25M

62.94%413.5M

16.95%205.43M

-27.18%212.08M

-40.83%242.21M

Free cash flow

29.97%-33.48M

-81.03%-56.16M

-29.86%-42.96M

-41.58%-163.4M

-69.42%-51.49M

-84.64%-47.81M

-15.92%-31.02M

-2.21%-33.08M

-51.38%-115.41M

-2.87%-30.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.91%-33.48M	-81.03%-56.16M	-30.01%-42.96M	-42.11%-163.28M	-69.41%-51.44M	-85.43%-47.77M	-16.71%-31.02M	-2.66%-33.04M	-52.34%-114.9M	-3.45%-30.37M
Net income from continuing operations	-36.81%-72.55M	-52.30%-58.7M	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M
Operating gains losses	----	----	----	----	----	----	----	----	-988.68%-577K	---316K
Depreciation and amortization	-9.83%156K	-6.43%160K	0.00%158K	12.46%668K	12.93%166K	18.49%173K	11.04%171K	7.48%158K	10.41%594K	12.21%147K
Other non cash items	-0.58%854K	-4.47%812K	-2.83%791K	338.98%67.38M	8,017.15%64.86M	-16.44%859K	181.46%850K	-93.84%814K	-90.29%15.35M	-0.50%799K
Change In working capital	2,567.23%29.43M	-277.22%-9.03M	1,062.14%3.59M	-28.08%-8.9M	-153.27%-13.11M	-314.95%-1.19M	194.62%5.1M	107.62%309K	-623.00%-6.95M	-15.56%-5.18M
-Change in prepaid assets	356.79%17.69M	-129.56%-9.74M	-6.45%7.35M	-214.25%-11.4M	-293.18%-8.13M	-642.46%-6.89M	-3,219.12%-4.24M	1,121.85%7.86M	-60.53%-3.63M	8.98%-2.07M
-Change in payables and accrued expense	91.93%12.6M	-84.97%1.53M	56.16%-2.96M	305.96%5.91M	-203.85%-4.07M	207.69%6.57M	466.28%10.16M	37.03%-6.75M	-149.41%-2.87M	133.39%3.92M
-Change in other current assets	----	----	----	--0	----	----	----	----	137.48%1.37M	-72.46%-6.25M
-Change in other current liabilities	0.92%-861K	-0.24%-822K	-0.12%-802K	-86.36%-3.4M	-16.90%-913K	-44.35%-869K	-310.00%-820K	-229.63%-801K	-117.12%-1.83M	-194.72%-781K
Cash from discontinued investing activities
Operating cash flow	29.91%-33.48M	-81.03%-56.16M	-30.01%-42.96M	-42.11%-163.28M	-69.41%-51.44M	-85.43%-47.77M	-16.71%-31.02M	-2.66%-33.04M	-52.34%-114.9M	-3.45%-30.37M
Investing cash flow
Cash flow from continuing investing activities	559.20%156.99M	-11.72%21.26M	-5,424.85%-150M	138.32%64.39M	270.32%13.68M	42.66%23.82M	126.44%24.08M	103.29%2.82M	-20,464.63%-168.01M	-4,171.28%-8.03M
Net PPE purchase and sale	--0	--0	--0	77.10%-117K	-91.30%-44K	71.54%-37K	--0	79.55%-36K	37.45%-511K	87.77%-23K
Net investment purchase and sale	558.18%156.99M	-11.72%21.26M	-5,330.49%-149.23M	144.72%69.09M	328.69%18.31M	41.78%23.85M	126.49%24.08M	103.94%2.85M	---154.5M	---8.01M
Net other investing changes	--0	--0	---775K	64.69%-4.59M	----	----	----	----	---13M	--0
Cash from discontinued investing activities
Investing cash flow	559.20%156.99M	-11.72%21.26M	-5,424.85%-150M	138.32%64.39M	270.32%13.68M	42.66%23.82M	126.44%24.08M	103.29%2.82M	-20,464.63%-168.01M	-4,171.28%-8.03M
Financing cash flow
Cash flow from continuing financing activities	-99.34%1.53M	808.90%2.65M	1,726.73%1.85M	100.39%231.94M	-101.79%-481K	166.15%232.02M	-85.98%292K	128.77%101K	-60.57%115.74M	7,595.25%26.83M
Net common stock issuance	----	----	----	--232.88M	---491K	----	----	----	--0	--0
Net preferred stock issuance	----	----	----	--0	----	----	----	----	-61.46%112.22M	39,738.10%24.97M
Proceeds from stock option exercised by employees	16.21%1.76M	556.93%2.65M	1,562.16%1.85M	-33.13%2.86M	-49.85%830K	949.31%1.51M	-82.50%404K	-32.32%111K	70.23%4.27M	95.63%1.66M
Net other financing activities	----	----	----	-411.29%-3.8M	-498.06%-820K	-1,262.86%-2.86M	50.22%-112K	98.06%-10K	34.79%-744K	--206K
Cash from discontinued financing activities
Financing cash flow	-99.34%1.53M	808.90%2.65M	1,726.73%1.85M	100.39%231.94M	-101.79%-481K	166.15%232.02M	-85.98%292K	128.77%101K	-60.57%115.74M	7,595.25%26.83M
Net cash flow
Beginning cash position	-26.06%151.89M	-13.18%184.14M	54.93%375.25M	-40.83%242.21M	62.94%413.5M	16.95%205.43M	-27.18%212.08M	-40.83%242.21M	113.10%409.37M	-42.23%253.77M
Current changes in cash	-39.91%125.04M	-384.80%-32.25M	-534.44%-191.11M	179.59%133.05M	-230.76%-38.25M	166.39%208.07M	94.24%-6.65M	74.50%-30.12M	-176.94%-167.17M	61.33%-11.56M
End cash Position	-33.03%276.93M	-26.06%151.89M	-13.18%184.14M	54.93%375.25M	54.93%375.25M	62.94%413.5M	16.95%205.43M	-27.18%212.08M	-40.83%242.21M	-40.83%242.21M
Free cash flow	29.97%-33.48M	-81.03%-56.16M	-29.86%-42.96M	-41.58%-163.4M	-69.42%-51.49M	-84.64%-47.81M	-15.92%-31.02M	-2.21%-33.08M	-51.38%-115.41M	-2.87%-30.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data